Drozitumab Antibody
Drozitumab (PRO 95780) is a fully human anti-DR5 agonistic antibody that induces apoptosis. It has demonstrated anti-tumor activity in preclinical studies of rhabdomyosarcoma and is a research tool for investigating triple-negative breast cancer in both in vitro and in vivo models.
Product Specifications
Product Name Alternative
Anti-Human DR5 Recombinant Antibody, PRO 95780, PRO95780, rhuMAb-DR 5, RG7425, RG 7425
Target
Apoptosis, TNF
Conjugation
Unconjugated
Field of Research
Cell Biology
Concentration
5.44 mg/mL
Purity
95.00% (May vary between batches)
Molecular Weight
143.09 kDa
Storage Conditions
Maintain refrigerated at 2-8°C for up to 2 weeks. For long term storage store at -20°C in small aliquots to prevent freeze-thaw cycles.
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
TL300471V 500 µL Each
WDR8 (WRAP73) Human shRNA Lentiviral Particle (Locus ID 49856)
Sign In for Pricing
View Details 
